Prehabilitation program for kidney transplant patients
Official title: The Effects of an Interdisciplinary Treatment Approach in ESRD Patients: a Randomised Controlled Trial
Run by University of Erlangen-Nürnberg Medical School · NCT06040281 · Data updated 2026-11-12
This study is testing if a special program that includes nutrition and exercise support can help kidney transplant patients get healthier before their surgery compared to just using an informational app.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University of Erlangen-Nürnberg Medical School Academic / other |
| Locations | 1 site (Erlangen, Bavaria) |
| Status | Recruiting |
| Started | September 18, 2023 |
| Main results expected | March 31, 2026 |
| Study ends | March 31, 2026 |
| Registry record updated | March 30, 2025 |
| Trial ID | NCT06040281 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are on dialysis and willing to participate in a rehabilitation program.
✕Probably not a fit
Patients who are not physically or psychologically able to engage in exercise or nutritional counseling may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of a comprehensive prehabilitation program that includes intensive nutritional and exercise support for patients with chronic kidney disease awaiting kidney transplantation. Participants are randomly assigned to either an intervention group, which receives personalized support and a three-week inpatient rehabilitation, or a control group that only has access to an informational app. The study measures various outcomes such as body composition, physical performance, blood values, quality of life, and nutritional status over a one-year period. The goal is to determine if prehabilitation can improve outcomes for patients prior to transplantation.
Why it matters
Potential benefit: If successful, this approach could enhance the physical and nutritional status of patients, potentially leading to better transplant outcomes.
How similar studies have gone: Other studies have shown promising results with prehabilitation approaches in various surgical populations, suggesting potential success for this intervention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients must be on dialysis * Patients ≥ 18 years of age * Patients who own a smartphone * Patients must be willing to undergo inpatient rehabilitation within the project period * signed informed consent and data protection regulation Exclusion Criteria: * Patients who are not psychologically or physically able to take part in exercise promotion measures and/or nutritional counselling as well as psychological offers * Patients who have already participated in a similar project
Where it's running
-
Universitätsklinikum Erlangen
Erlangen, Bavaria, Germany Recruiting
Study contacts
- Study coordinator: Helge Krusemark
- Email: helge.krusemark@uk-erlangen.de
- Phone: +4991318542966
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pumpkin seed oil for people on hemodialysis
This study tests whether taking pumpkin seed oil daily for 3 months helps reduce inflammation and improve-related lab markers in people with end-stage kidney disease on dialysis.
-
How dialysis affects sexual function and intimacy
This project will see how dialysis affects sexual health and intimacy in adults who have been on hemodialysis or peritoneal dialysis for at least six months.
-
Using body composition and kidney function measurements to assess nutrition in hemodialysis patients
This study is testing if using body composition and kidney function measurements can help better understand the nutrition of people on hemodialysis.
-
AP306 at fixed doses in adults on dialysis with high phosphate
This trial tests if AP306, taken daily at different doses, can safely lower phosphate levels in adults on maintenance dialysis with hyperphosphatemia.
-
Dialysis that removes more middle molecules using super high‑flux filters
This trial will test whether using super high‑flux (expanded) dialysis filters instead of standard high‑flux filters reduces the risk of death and other harms for adults on in‑center hemodialysis who are older or have diabetes.
-
How kidney failure changes antibody responses to influenza and COVID vaccines
This project will see if adults on chronic dialysis make as much protective antibody after influenza or SARS‑CoV‑2 vaccination as people without kidney disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.